Rhumbline Advisers Axonics, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Axonics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 71,723 shares of AXNX stock, worth $5.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

71,723

Previous 78,401 8.52%

Holding current value

$5.09 Million

Previous $5.27 Million 5.2%

% of portfolio

0.0%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$67.3 - $69.67 $449,429 - $465,256	-6,678 Reduced 8.52%	71,723 $5 Million
Q2 2024 Aug 01, 2024	BUY	$66.47 - $69.65 $627,875 - $657,913	9,446 Added 13.7%	78,401 $5.27 Million
Q1 2024 May 09, 2024	SELL	$56.67 - $69.36 $32,981 - $40,367	-582 Reduced 0.84%	68,955 $4.76 Million
Q4 2023 Feb 08, 2024	SELL	$49.38 - $63.75 $2,222 - $2,868	-45 Reduced 0.06%	69,537 $4.33 Million
Q3 2023 Nov 09, 2023	BUY	$48.64 - $62.51 $49,904 - $64,135	1,026 Added 1.5%	69,582 $3.9 Million
Q2 2023 Aug 08, 2023	BUY	$47.99 - $60.21 $87,725 - $110,063	1,828 Added 2.74%	68,556 $3.46 Million
Q1 2023 May 11, 2023	BUY	$52.6 - $67.34 $66,959 - $85,723	1,273 Added 1.94%	66,728 $3.64 Million
Q4 2022 Feb 14, 2023	BUY	$59.56 - $76.6 $271,057 - $348,606	4,551 Added 7.47%	65,455 $4.09 Million
Q3 2022 Nov 10, 2022	BUY	$57.96 - $78.12 $346,253 - $466,688	5,974 Added 10.88%	60,904 $4.29 Million
Q2 2022 Aug 11, 2022	BUY	$39.5 - $64.42 $279,778 - $456,286	7,083 Added 14.8%	54,930 $3.11 Million
Q1 2022 May 12, 2022	BUY	$43.74 - $62.76 $99,071 - $142,151	2,265 Added 4.97%	47,847 $3 Million
Q4 2021 Feb 10, 2022	SELL	$50.01 - $73.35 $5,551 - $8,141	-111 Reduced 0.24%	45,582 $2.55 Million
Q3 2021 Nov 12, 2021	BUY	$59.21 - $78.66 $218,307 - $290,019	3,687 Added 8.78%	45,693 $2.97 Million
Q2 2021 Aug 05, 2021	BUY	$51.39 - $66.9 $433,526 - $564,368	8,436 Added 25.13%	42,006 $2.66 Million
Q1 2021 May 06, 2021	SELL	$49.14 - $59.89 $192,923 - $235,128	-3,926 Reduced 10.47%	33,570 $2.01 Million
Q4 2020 Feb 10, 2021	BUY	$42.19 - $51.5 $26,748 - $32,651	634 Added 1.72%	37,496 $1.87 Million
Q3 2020 Nov 12, 2020	SELL	$35.33 - $51.04 $200,957 - $290,315	-5,688 Reduced 13.37%	36,862 $1.88 Million
Q2 2020 Aug 13, 2020	BUY	$22.91 - $39.83 $503,974 - $876,180	21,998 Added 107.04%	42,550 $1.49 Million
Q1 2020 May 06, 2020	BUY	$16.44 - $37.73 $49,221 - $112,963	2,994 Added 17.05%	20,552 $522,000
Q4 2019 Feb 05, 2020	BUY	$19.57 - $28.96 $6,634 - $9,817	339 Added 1.97%	17,558 $487,000
Q3 2019 Oct 23, 2019	BUY	$26.92 - $42.41 $2,638 - $4,156	98 Added 0.57%	17,219 $464,000
Q2 2019 Aug 14, 2019	BUY	$18.54 - $40.97 $317,423 - $701,447	17,121 New	17,121 $701,000

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Axonics, Inc. Transaction History